The McKesson Specialty Health iKnowMed℠ electronic health record platform earned top ratings in several key performance areas in the prestigious KLAS Performance Report, Oncology 2016: Navigating The Oncology IT Road Map, confirming that iKnowMed is a top oncology-specific EHR choice for community-based oncology practices who are navigating a changing medical oncology EHR landscape.
KLAS is a leading independent healthcare research firm whose reports are utilized by thousands of healthcare decision-makers around the world. Extremely well-liked among oncologists, iKnowMed earned the highest ratings among medical oncology vendors for functionality, integration and workflow, leading the medical oncology market in these important performance areas.
“We are extremely proud of iKnowMed’s KLAS performance ratings in several critical oncology performance areas,” said Dan Lodder, vice president and general manager of Technology Solutions for McKesson Specialty Health. “This report is further verification that iKnowMed leads the industry in oncology-specific EHR solutions and is an invaluable tool that can help community-based oncologists succeed in the evolving environment of alternative payment models. We have established a tradition of excellence with this product that is setting a whole new standard for oncology EHRs,” he concluded.
Developed in collaboration with oncologists in The US Oncology Network, iKnowMed is the only next generation EHR for oncology and hematology available today and has been recognized for five consecutive years as the top-performing EHR for oncology and hematology practices by Black Book Rankings. iKnowMed is found in over 620 sites of care and is used by more than 1,600 providers to support the delivery of quality care. It seamlessly integrates with McKesson Specialty Health’s other leading technology solutions designed specifically for oncology to enable value-based care delivery while strengthening core practice operations.
“This KLAS data supports what physicians using iKnowMed have already discovered―iKnowMed is an investment in an innovative technology platform that can efficiently drive and support high-quality care as practices transition to the new performance-based environment,” said Mark Sitarik, M.D., medical oncologist with Rocky Mountain Cancer Centers and medical director of Technology for McKesson Specialty Health. “It is designed to meet the future of oncology head on, empowering clinicians to deliver evidence-based, cost-efficient team care while providing the best possible patient experience.”
McKesson Specialty Health’s comprehensive practice solution provides flexibility to meet ever-changing conditions through integrated modules that focus on critical areas of concern in today’s evolving healthcare environment. Key modules include clinical quality and regimen support, patient engagement, inventory & procurement optimization, revenue cycle management as well as data analytics required for alternative payment models, value-based care and revenue optimization.
For more information about iKnowMed or to request a demonstration, please visit mckessonspecialtyhealth.com/iknowmed.
About McKesson Specialty Health
McKesson Specialty Health, a division of McKesson Corporation, empowers the community patient care delivery system by helping community practices advance the science, technology and quality of care. Through innovative clinical research, business and operational solutions, facilitated by integrated technology systems, we focus on improving the financial health of our customers so they may provide the best care to their patients. For more information, visit www.mckessonspecialtyhealth.com.
About KLAS
KLAS is a research and insights firm on a global mission to improve healthcare delivery by amplifying the provider’s voice. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software, services and medical equipment to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Follow KLAS on Twitter at www.twitter.com/KLASresearch.
Contacts
McKesson Specialty Health
Claire Crye, 281-825-9927
Claire.Crye@mckesson.com
